Using biomarkers and early prophylactic treatment to prevent cardiotoxicity in cancer patients on chemotherapy
Cardiac toxicity induced by anticancer therapy is of considerable concern for, once it develops, it may compromise the clinical effectiveness of treatment independent of the oncologic prognosis. The main strategy to minimize cardiotoxicity is to detect high-risk patients and begin prophylactic treat...
Guardado en:
Autores principales: | Giulia Bacchiani, Daniela Cardinale |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
South African Heart Association
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12f648ef49e640cfa4136c500eecbf4d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiotoxic effects induced by the use of antimetabolites in the chemotherapy of oncological diseases
por: Alina A. Aliab'eva, et al.
Publicado: (2021) -
Prognostic value of GLS for early prediction of chemotherapy induced cardiotoxicity
por: Sumit Vipin Kumar, et al.
Publicado: (2021) -
Non-invasive cardiac imaging for evaluation of cardiotoxicity in cancer patients - early detection and follow-up
por: Gabriel Vorobiof, et al.
Publicado: (2017) -
Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction
por: Huiyu Xiao, et al.
Publicado: (2021) -
Successful Prevention of Fetal Autoimmune-Mediated Heart Block by Combined Therapies With Hydroxychloroquine and Intravenous Immunoglobulin: A Case Report
por: Li Zhao, et al.
Publicado: (2021)